Li Q J, Ashraf F M, Rana T S, Tuli S, Mai E L, Adler R A, Reviglio V E, O'Brien T P
Ocular Microbiology and Immunology Laboratory, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-9121, USA.
Curr Eye Res. 2001 Nov;23(5):336-45. doi: 10.1076/ceyr.23.5.336.5442.
To investigate the capability of cultivated allogeneic epithelial stem cells to restore a functional ocular surface in a limbal deficient cornea; to verify the long term survival of epithelial allograft; and to examine the host immune response to heterologous cell transplant in a rabbit model.
Limbal deficiency was established by performing limbectomy on rabbits (n = 100). Corneal epithelial stem cells were obtained from the limbus and replicated in vitro without a supporting layer. The cell (3 x 10(5)) suspension was then transplanted via topical application as eye drops. Animals were divided into allograft, autograft, and control groups. Females were used as recipients and males as donors for the allograft. Corneas were collected at 7, 14, 21, 40 days as well as 2, 3, 7 and 8 months after cell transplantation. Experimental corneas were evaluated by histology, immunofluorescence, immunohistochemistry and Y chromosome analysis.
A well-differentiated corneal epithelium was recognized at 14 to 40 days after cell transfer overlying an infiltrated corneal stroma. Corneal re-epitheliazation was confirmed in 31 of 36 allograft corneas. No significant immune rejection was noted. Stromal abnormality caused by previous limbal deficiency was mostly resolved three months after the regeneration of corneal epithelium.
Transplanted corneal epithelial stem cells were able to differentiate into normal corneal epithelium in vivo without the use of membrane scaffolding. This non-autologous donor cell-derived corneal epithelium survived up to 8 months without immunosuppression and was able to reverse the stromal scarring. Thus, cultivated epithelial stem cells have great potential as an alternative to multiple-surgical procedures in the treatment of limbal deficiency states.
研究培养的同种异体上皮干细胞恢复角膜缘缺陷角膜功能性眼表的能力;验证上皮移植片的长期存活情况;并在兔模型中检测宿主对异种细胞移植的免疫反应。
通过对兔(n = 100)进行角膜缘切除术建立角膜缘缺陷模型。从角膜缘获取角膜上皮干细胞并在无支持层的情况下进行体外复制。然后将细胞悬液(3×10⁵)通过滴眼剂局部应用进行移植。动物分为同种异体移植组、自体移植组和对照组。同种异体移植中,雌性作为受体,雄性作为供体。在细胞移植后7天、14天、21天、40天以及2个月、3个月、7个月和8个月收集角膜。通过组织学、免疫荧光、免疫组织化学和Y染色体分析对实验性角膜进行评估。
细胞移植后14至40天,在浸润的角膜基质上方可识别出分化良好的角膜上皮。36只同种异体移植角膜中有31只证实角膜重新上皮化。未观察到明显的免疫排斥反应。角膜上皮再生3个月后,先前角膜缘缺陷引起的基质异常大多得到解决。
移植的角膜上皮干细胞在不使用膜支架的情况下能够在体内分化为正常的角膜上皮。这种非自体供体细胞来源的角膜上皮在无免疫抑制的情况下存活长达8个月,并能够逆转基质瘢痕形成。因此,培养的上皮干细胞作为治疗角膜缘缺陷状态的多手术方法的替代方案具有巨大潜力。